SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Pharmacy Practice
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Levy, S. B.
Right arrow Articles by Cohen, H.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Screening, Diagnosis, and Pharmacotherapy for Type 2 Diabetes Mellitus

Steven B. Levy, BS, PharmD, CGP

Henry Cohen, MS, PharmD, BCPP, CGP

Type 2 diabetes is increasing in prevalence. It is pragmatic to screen patients for diagnostic testing. Diet, exercise, and oral therapy remain the primary treatment modalities for type 2 diabetes. First generation sulfonylureas have fallen out of favor due to adverse effects. Second generation sulfonylureas, metformin, or their combinations are recommended first-line. Glipizide and glimepiride are preferred in elderly, hepatically, and renally impaired patients. Metformin is not recommended with chronic heart failure, renal insufficiency, and in the elderly due to lactic acidosis risks. Glitazones are for second-line therapy, should be used cautiously with cardiac insufficiencies, and require routine monitoring of liver enzymes. Meglitinides, not first-line, may offer an alternative to sulfonylureas. Alpha-glucosidase inhibitors, most effective with impaired glucose tolerance, may be combined with sulfonylureas or metformin. Pharmacists play an integral role in management and pharmacotherapy services in diabetes may be implemented in collaborative drug therapy monitoring for maximizing cost effectiveness.

Key Words: Diabetes • antidiabetics • sulfonylureas • metformin • hemaglobin-A1c

Journal of Pharmacy Practice, Vol. 16, No. 2, 127-137 (2003)
DOI: 10.1177/0897190003016002008
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




Advertisement